| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10962786 | Vaccine | 2016 | 7 Pages |
Abstract
This proof of concept evaluation showed that a new application of SMS technology is feasible to implement in a LMIC with high user satisfaction. Larger studies with modifications in the SMS system are needed to determine effectiveness (Clinical Trial Registry NCT01663636).
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Gretchen J. Domek, Ingrid L. Contreras-Roldan, Sean T. O'Leary, Sheana Bull, Anna Furniss, Allison Kempe, Edwin J. Asturias,